EDGAR Filing Documents for 0001052918-21-000246

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001052918-21-000246

Filing Date

2021-06-28

Accepted

2021-06-28 16:54:41

Documents

Period of Report

2021-01-31

Document Format Files

Seq	Description	Document	Type	Size
1	AVRICORE HEALTH INC.	avricore6kjan2021.htm	6-K	10221
2	EXHIBIT 99.1	nr_ex99z1.htm	EX-99.1	10830
3	EXHIBIT 99.2	nr_ex99z2.htm	EX-99.2	12296
4	EXHIBIT 99.3	nr_ex99z3.htm	EX-99.3	12844
5	EXHIBIT 99.4	nr_ex99z4.htm	EX-99.4	5863
6	IMAGE	nrex99z1_1.jpg	GRAPHIC	6702
7	IMAGE	nrex99z2_1.jpg	GRAPHIC	6702
8	IMAGE	nrex99z3_1.jpg	GRAPHIC	6702
9	IMAGE	nrex99z4_1.jpg	GRAPHIC	6933
	Complete submission text file	0001052918-21-000246.txt		91176

Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2

Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038

Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)